News
09-07-2011, 02:10 AM
Nearly half of breast cancer patients carrying the BRCA1 gene mutation experience a complete pathological response (pCR) the disappearance of all evidence of disease from the breast tissue and lymph nodes regardless of disease stage after standard neoadjuvent chemotherapy, according to new research from The University of Texas MD Anderson Cancer Center...
More... (http://www.medicalnewstoday.com/releases/233965.php)
More... (http://www.medicalnewstoday.com/releases/233965.php)